--2025/Q1-- / 68.702M--
--2024/Q4-- / 57.133M--
Nov 12, 20242024/Q349.301M / 55.139M--
Aug 7, 20242024/Q259.733M / 34.580M--
May 2, 20242024/Q121.006M / 13.068M--
US Stock MarketDetailed Quotes
SWTX SpringWorks Therapeutics
- 41.480
- -0.250-0.60%
Close Nov 29 13:00 ET
- 42.607
- +1.127+2.72%
Post 17:01 ET
3.09BMarket Cap-10663P/E (TTM)
41.850High40.850Low645.35KVolume41.360Open41.730Pre Close26.80MTurnover0.93%Turnover RatioLossP/E (Static)74.39MShares53.92052wk High5.79P/B2.87BFloat Cap28.21052wk Low--Dividend TTM69.09MShs Float96.480Historical High--Div YieldTTM2.40%Amplitude13.600Historical Low41.526Avg Price1Lot Size
SpringWorks Therapeutics Key Stats
SpringWorks Therapeutics Q3 2024 Earnings Date
Currency：USDNov 12, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 55.14M | 49.30M | -5.84M |
| Miss Est. | -- | -- | -10.59% |
| EPS | -0.75 | -0.72 | +0.03 |
| Beat Est. | +40.69% | +43.31% | +4.41% |
Analyst Rating
Dec 1, 2024
SpringWorks Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
SpringWorks Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data